Dopamine Agonists (administration & dosage) < Dopamine Agonists (adverse effects) < Dopamine Agonists (blood)

Facettes :

List of bibliographic references indexed by Dopamine Agonists (adverse effects)

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000542 (2015)	Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada]	Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
000585 (2015)	Michele Tinazzi ; Alfonso Fasano ; Christian Geroin ; Francesca Morgante ; Roberto Ceravolo ; Simone Rossi ; Astrid Thomas ; Giovanni Fabbrini ; Annarita Bentivoglio ; Filippo Tamma ; Giovanni Cossu ; Nicola Modugno ; Mario Zappia ; Maria Antonietta Volontè ; Carlo Dallocchio ; Giovanni Abbruzzese ; Claudio Pacchetti ; Roberto Marconi ; Giovanni Defazio ; Margherita Canesi ; Antonino Cannas ; Antonio Pisani ; Rina Mirandola ; Paolo Barone ; Carmine Vitale	Pisa syndrome in Parkinson disease: An observational multicenter Italian study.
000601 (2015)	Philip Seeman [Canada]	Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
000642 (2015)	I. Aracil-Bola Os [Canada] ; A. P. Strafella [Canada]	Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease
000941 (2014)	Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada]	Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
000A45 (2014)	Franziska Maier [Allemagne] ; Josuah Merkl [Allemagne] ; Anna L. Ellereit [Allemagne] ; Catharine J. Lewis [Allemagne] ; Carsten Eggers [Allemagne] ; David J. Pedrosa [Allemagne] ; Elke Kalbe [Allemagne] ; Jens Kuhn [Allemagne] ; Thomas D. Meyer [Royaume-Uni] ; Mateusz Zurowski [Canada] ; Lars Timmermann [Allemagne]	Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.
000D75 (2013)	Abdul Qayyum Rana [Canada] ; Wasim Mansoor ; Syed Hussaini ; Abdullah Al Mosabbir ; Maniza Rahman ; Labiba Rahman	Factors associated with the development of impulse compulsive disorders in Parkinson patients.
000F04 (2013)	Margarita Pondal [Canada] ; Connie Marras [Canada] ; Janis Miyasaki [Canada] ; Elena Moro [Canada] ; Melissa J. Armstrong [Canada] ; Antonio P. Strafella [Canada] ; Binit B. Shah [Canada] ; Susan Fox [Canada] ; L K Prashanth [Canada] ; Nicolas Phielipp [Canada] ; Anthony E. Lang [Canada]	Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
001234 (2012)	Nicola J. Ray [Canada] ; Janis M. Miyasaki [Canada] ; Mateusz Zurowski [Canada] ; Ji Hyun Ko [Canada] ; Sang Soo Cho [Canada] ; Giovanna Pellecchia [Canada] ; Francesca Antonelli [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada]	Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study
001A62 (2010)	Waqas Khan [Canada] ; Abdul Qayyum Rana	Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient.
002146 (2008)	V. Chatsis	Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.
002151 (2008)	David Crockford [Canada] ; Jeremy Quickfall ; Shawn Currie ; Sarah Furtado ; Oksana Suchowersky ; Nady El-Guebaly	Prevalence of problem and pathological gambling in Parkinson's disease.
002176 (2008)	Ramin Zand [Canada]	Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?
002204 (2008)		Dopamine agonist: pathological gambling and hypersexuality.
002387 (2008)	Cindy Zadikoff [Canada, États-Unis] ; Minh Duong-Hua [Canada] ; Kathy Sykora [Canada] ; Connie Marras [Canada] ; Anthony Lang [Canada] ; Paula Rochon [Canada]	Pergolide Associated Cardiac Valvulopathy Based on Ontario Administrative Data
002691 (2007)	R. M. A. De Bie [Canada, Pays-Bas] ; J. Miyasaki [Canada] ; A. E. Lang [Canada] ; S. H. Fox [Canada]	Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease
002D10 (2004)	Ajmal Razmy [Canada] ; Anthony E. Lang [Canada] ; Colin M. Shapiro [Canada]	Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists
002E96 (2003)	W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada]	Treatment of Parkinson's disease
002F45 (2003)	Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]	Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis
002F55 (2002)	J F Gagnon [Canada] ; J. Montplaisir ; M A Bédard	[Rapid-eye-movement sleep disorders in Parkinson's disease].
003310 (2001)	Mahyar Etminan [Canada] ; Ali Samii [États-Unis] ; Bahi Takkouche [Espagne] ; Paula A. Rochon [Canada]	Increased risk of somnolence with the new dopamine agonists in Patients with Parkinson's disease: A meta-analysis of randomised controlled trials

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Agonists (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Agonists (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agonists (adverse effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022